{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:07:16Z","timestamp":1776082036337,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Education Reforming Program, Peking Union Medical College","award":["2018zlgc0119"],"award-info":[{"award-number":["2018zlgc0119"]}]},{"name":"Education Reforming Program, Peking Union Medical College","award":["2018zlgc0119"],"award-info":[{"award-number":["2018zlgc0119"]}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873641"],"award-info":[{"award-number":["81873641"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03204-7","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T18:02:51Z","timestamp":1665511371000},"page":"605-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Full-length versus intact PTH concentrations in pseudohypoparathyroidism type 1 and primary hyperparathyroidism: clinical evaluation of immunoassays in individuals from China"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4563-371X","authenticated-orcid":false,"given":"Yi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6572-1827","authenticated-orcid":false,"given":"Ailing","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-5177","authenticated-orcid":false,"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8228-5078","authenticated-orcid":false,"given":"Xinqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0395-8789","authenticated-orcid":false,"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"3204_CR1","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1210\/endo-104-6-1778","volume":"104","author":"GP Mayer","year":"1979","unstructured":"G.P. Mayer, J.A. Keaton, J.G. Hurst, J.F. Habener, Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood. Endocrinology 104, 1778 (1979)","journal-title":"Endocrinology"},{"key":"3204_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1042\/cs0570435","volume":"57","author":"MA Dambacher","year":"1979","unstructured":"M.A. Dambacher, J.A. Fischer, W.H. Hunziker, W. Born, J. Moran, H.R. Roth et al. Distribution of circulating immunoreactive components of parathyroid hormone in normal subjects and in patients with primary and secondary hyperparathyroidism: The role of the kidney and of the serum calcium concentration. Clin. Sci. 57, 435 (1979)","journal-title":"Clin. Sci."},{"key":"3204_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","volume":"44","author":"R Lepage","year":"1998","unstructured":"R. Lepage, L. Roy, J.H. Brossard, L. Rousseau, C. Dorais, C. Lazure et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin. Chem. 44, 805 (1998)","journal-title":"Clin. Chem."},{"key":"3204_CR4","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1515\/cclm-2014-0150","volume":"52","author":"L Couchman","year":"2014","unstructured":"L. Couchman, D.R. Taylor, B. Krastins, M.F. Lopez, C.F. Moniz, LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations. Clin. Chem. Lab. Med 52, 1251 (2014)","journal-title":"Clin. Chem. Lab. Med"},{"key":"3204_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","volume":"16","author":"P Gao","year":"2001","unstructured":"P. Gao, S. Scheibel, P. D\u2019Amour, M.R. John, S.D. Rao, H. Schmidt-Gayk et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function. J. Bone Miner. Res 16, 605 (2001)","journal-title":"J. Bone Miner. Res"},{"key":"3204_CR6","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1210\/jc.2002-021266","volume":"88","author":"SJ Silverberg","year":"2003","unstructured":"S.J. Silverberg, P. Gao, I. Brown, P. Logerfo, T.L. Cantor, J.P. Bilezikian, Clinical Utility of an Immunoradiometric Assay for Parathyroid Hormone (1-84) in Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 88, 4725 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3204_CR7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1373\/clinchem.2003.026328","volume":"50","author":"V Carnevale","year":"2004","unstructured":"V. Carnevale, S. Dionisi, I. Nofroni, E. Romagnoli, F. Paglia, S. De Geronimo et al. Potential Clinical Utility of a New IRMa for Parathyroid Hormone in Postmenopausal Patients with Primary Hyperparathyroidism. Clin. Chem. 50, 626 (2004)","journal-title":"Clin. Chem."},{"key":"3204_CR8","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1210\/jc.2005-0715","volume":"90","author":"P Boudou","year":"2005","unstructured":"P. Boudou, F. Ibrahim, C. Cormier, A. Chabas, E. Sarfati, J.C. Souberbielle, Third- or second-generation parathyroid hormone assays: A remaining debate in the diagnosis of primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 90, 6370 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3204_CR9","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop. J. Clin. Endocrinol. Metab. 99, 3561 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3204_CR10","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1210\/jc.2002-021610","volume":"88","author":"Y Hatakeyama","year":"2003","unstructured":"Y. Hatakeyama, K. Mizunashi, Y. Furukawa, S. Yabuki, Y. Sato, T. Igarashi, Plasma levels of parathyroid hormone (1-84) whole molecule and parathyroid hormone (7-84)-like fragments in pseudohypoparathyroidism type I. J. Clin. Endocrinol. Metab. 88, 2250 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3204_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cen.13516","volume":"88","author":"X Chu","year":"2018","unstructured":"X. Chu, Y. Zhu, O. Wang, M. Nie, T. Quan, Y. Xue et al. Clinical and genetic characteristics of Pseudohypoparathyroidism in the Chinese population. Clin. Endocrinol. 88, 285 (2018)","journal-title":"Clin. Endocrinol."},{"key":"3204_CR12","first-page":"4630","volume":"86","author":"W Ahrens","year":"2001","unstructured":"W. Ahrens, O. Hiort, P. Staedt, T. Kirschner, C. Marschke, K. Kruse, Analysis of the GNAS1 Gene in Albright\u2019s Hereditary Osteodystrophy. J. Clin. Endocrinol. Metab. 86, 4630 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3204_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1373\/clinchem.2003.026831","volume":"50","author":"M Inaba","year":"2004","unstructured":"M. Inaba, K. Nakatsuka, Y. Imanishi, M. Watanabe, Y. Mamiya, E. Ishimura et al. Technical and Clinical Characterization of the Bio-PTH (1-84) Immunochemiluminometric Assay and Comparison with a Second-Generation Assay for Parathyroid Hormone. Clin. Chem. 50, 385 (2004)","journal-title":"Clin. Chem."},{"key":"3204_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.biopha.2005.11.001","volume":"60","author":"M Inaba","year":"2006","unstructured":"M. Inaba, S. Okuno, H. Chou, Y. Imanishi, M. Ueda, T. Yamakawa et al. Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients. Biomed. Pharmacother. 60, 62 (2006)","journal-title":"Biomed. Pharmacother."},{"key":"3204_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ki.1993.323","volume":"44","author":"G Hercz","year":"1993","unstructured":"G. Hercz, Y. Pei, C. Greenwood, A. Manuel, C. Saiphoo, W.G. Goodman et al. Aplastic osteodystrophy without aluminum: The role of \u201csuppressed\u201d parathyroid function. Kidney Int 44, 860 (1993)","journal-title":"Kidney Int"},{"key":"3204_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1744-9987.2011.00927.x","volume":"15","author":"T Kakuta","year":"2011","unstructured":"T. Kakuta, H. Kato, H. Komaba, T. Akizawa, Parathyroid Hormone Control Survey to Determine Inter-method and Inter-lab Variations in Japan. Ther. Apher. Dial. 15, 50 (2011)","journal-title":"Ther. Apher. Dial."},{"key":"3204_CR17","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1080\/0886022X.2021.1931318","volume":"43","author":"H Chen","year":"2021","unstructured":"H. Chen, W. Ren, Z. Gao, M. Zeng, S. Tang, F. Xu et al. Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients. Ren. Fail. 43, 890 (2021)","journal-title":"Ren. Fail."},{"key":"3204_CR18","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1373\/clinchem.2007.085506","volume":"53","author":"MR Rubin","year":"2007","unstructured":"M.R. Rubin, S.J. Silverberg, P. D\u2019Amour, J.H. Brossard, L. Rousseau, J. Sliney et al. An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1-84) is overproduced in parathyroid carcinoma. Clin. Chem. 53, 1470 (2007)","journal-title":"Clin. Chem."},{"key":"3204_CR19","doi-asserted-by":"publisher","first-page":"E453","DOI":"10.1210\/jc.2013-3730","volume":"99","author":"E Cavalier","year":"2014","unstructured":"E. Cavalier, D. Betea, M.L. Schleck, R. Gadisseur, L. Vroonen, P. Delanaye et al. The third\/second generation PTH assay ratio as a marker for parathyroid carcinoma: Evaluation using an automated platform. J. Clin. Endocrinol. Metab. 99, E453 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3204_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0953-6205(01)00124-8","volume":"12","author":"J Casez","year":"2001","unstructured":"J. Casez, R. Pfammatter, Q. Nguyen, K. Lippuner, P. Jaeger, Diagnostic approach to hypercalcemia: relevance of parathyroid hormone and parathyroid hormone-related protein measurements. Eur. J. Intern. Med. 12, 344 (2001)","journal-title":"Eur. J. Intern. Med."},{"key":"3204_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","volume":"14","author":"G Mantovani","year":"2018","unstructured":"G. Mantovani, M. Bastepe, D. Monk, L. de Sanctis, S. Thiele, A. Usardi et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat. Rev. Endocrinol. 14, 476 (2018)","journal-title":"Nat. Rev. Endocrinol."},{"key":"3204_CR22","first-page":"e928301","volume":"27","author":"M W\u00f3jtowicz","year":"2020","unstructured":"M. W\u00f3jtowicz, W. Piechota, Z. Wa\u0144kowicz, J. Smoszna, S. Niemczyk, Comparison of second- And third-generation parathyroid hormone test results in patients with chronic kidney disease. Med. Sci. Monit. 27, e928301 (2020)","journal-title":"Med. Sci. Monit."},{"key":"3204_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1373\/clinchem.2005.060962","volume":"52","author":"P Boudou","year":"2006","unstructured":"P. Boudou, F. Ibrahim, C. Cormier, E. Sarfati, J. Souberbielle, Unexpected Serum Parathyroid Hormone Profiles in Some Patients with Primary Hyperparathyroidism. Clin. Chem. 52, 757 (2006)","journal-title":"Clin. Chem."},{"key":"3204_CR24","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1359\/JBMR.0301251","volume":"19","author":"M Rubin","year":"2004","unstructured":"M. Rubin, P. D\u2019Amour, T. Cantor, J. Bilezikian, S. Silverberg, A molecular form of PTH distinct from PTH (1\u201384) is produced in parathyroid carcinoma. J. Bone Min. Res 19, S327 (2004)","journal-title":"J. Bone Min. Res"},{"key":"3204_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2265.2005.02286.x","volume":"62","author":"A R\u00e4kel","year":"2005","unstructured":"A. R\u00e4kel, J.H. Brossard, J.V. Patenaude, C. Albert, E. Nassif, T. Cantor et al. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: Influence of medical treatment and surgery. Clin. Endocrinol. (Oxf.). 62, 721 (2005)","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"3204_CR26","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","volume":"84","author":"MR John","year":"1999","unstructured":"M.R. John, W.G. Goodman, P. Gao, T.L. Cantor, I.B. Salusky, H. Juppner, A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure. J. Clin. Endocrinol. Metab. 84, 4287 (1999)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03204-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03204-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03204-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:12:41Z","timestamp":1744207961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03204-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3204"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03204-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest. All authors contributed to the article and approved the submitted version.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}